Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Meningioma”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT01076530
What this trial is testing

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+31 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02648997
What this trial is testing

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

Who this might be right for
Meningiomas
Dana-Farber Cancer Institute 40
Testing effectiveness (Phase 2)Looking for participantsNCT05425004
What this trial is testing

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Who this might be right for
Meningioma
Baptist Health South Florida 24
Testing effectiveness (Phase 2)Looking for participantsNCT06326190
What this trial is testing

177Lu-DOTATATE for Recurrent Meningioma

Who this might be right for
Recurrent Meningioma
European Organisation for Research and Treatment of Cancer - EORTC 136
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Testing effectiveness (Phase 2)WithdrawnNCT06012929
What this trial is testing

ONC201 for Refractory Meningioma

Who this might be right for
MeningiomaRefractory MeningiomaRelapsed Meningioma
University of Nebraska
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT02162732
What this trial is testing

Molecular-Guided Therapy for Childhood Cancer

Who this might be right for
NeuroblastomaMedulloblastomaGlioma+16 more
Giselle Sholler 186
Testing effectiveness (Phase 2)Looking for participantsNCT07150806
What this trial is testing

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Who this might be right for
Recurrent Meningioma
Joshua Palmer 30
Early research (Phase 1)UnknownNCT00360854
What this trial is testing

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 48
Early research (Phase 1)Temporarily pausedNCT07353229
What this trial is testing

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Who this might be right for
High Risk MeningiomaRecurrent Meningioma
Thomas Jefferson University 24
Testing effectiveness (Phase 2)Looking for participantsNCT04659811
What this trial is testing

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Who this might be right for
Grade I Meningioma, AdultGrade II Meningioma, AdultGrade III Meningioma, Adult+1 more
Nancy Ann Oberheim Bush, MD 37
Testing effectiveness (Phase 2)Study completedNCT00045734
What this trial is testing

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Who this might be right for
Adult Grade I MeningiomaAdult Grade II MeningiomaAdult Grade III Meningioma+3 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT04082520
What this trial is testing

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Who this might be right for
Grade 1 MeningiomaGrade 2 MeningiomaGrade 3 Meningioma+2 more
Mayo Clinic 41
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT02523014
What this trial is testing

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Who this might be right for
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT03604978
What this trial is testing

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

Who this might be right for
Grade 2 MeningiomaGrade 3 MeningiomaRecurrent Meningioma
National Cancer Institute (NCI) 38
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Load More Results